Transplantation of purified CD34+ cells in the treatment of critical limb ischemia

Journal of Vascular Surgery

Volumn 58, Issue 2, 2013, Pages

  Dong, Zhihui ^a   Chen, Bin ^a   Fu, Weiguo ^a   Wang, Yuqi ^a   Guo, Daqiao ^a   Wei, Zheng ^a   Xu, Xin ^a   Mendelsohn, Farrell Owen ^b  

^a FUDAN UNIVERSITY   (China)

^b Center for Therapeutic Angiogenesis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; NARCOTIC ANALGESIC AGENT;

ABOVE KNEE AMPUTATION; ADULT; AGED; ANKLE BRACHIAL INDEX; APHERESIS; BELOW KNEE AMPUTATION; BONE MARROW TRANSPLANTATION; CD34+ T LYMPHOCYTE; CELL ISOLATION; CELL THERAPY; CELL TRANSDIFFERENTIATION; CLINICAL ARTICLE; CONFERENCE PAPER; CRITICAL LIMB ISCHEMIA; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; IMMUNOMAGNETIC SEPARATION; KNEE PAIN; LIMB SALVAGE; LOW DRUG DOSE; MALE; OXYGEN TENSION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVASCULARIZATION; T LYMPHOCYTE; TREATMENT OUTCOME; WALKING SPEED;

EID: 84880825342     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2013.01.037     Document Type: Conference Paper

References (29)

1. C. Setacci Critical limb ischemia. New developments and perspectives 2010 Edizioni Minerva Medica Turin
2. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G. Fowkes TASC II Working Group Inter-Society concensus for the management of peripheral arterial disease (TASC II) J Vasc Surg 45 suppl S 2007 S5 67
3. G.P. Fadini, C. Agostini, and A. Avogaro Autologous stem cell therapy for peripheral arterial disease Meta-analysis and systematic review of the literature Atherosclerosis 209 2010 10 17
4. T. Ohta, H. Ishioashi, M. Hosaka, and I. Sugimoto Clinical and social consequences of Buerger disease J Vasc Surg 39 2004 176 180
5. E. Tateishi-Yuyama, H. Matsubara, T. Murohara, U. Ikeda, S. Shintani, and H. Masaki Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial Lancet 360 2002 427 435
6. S. Matoba, T. Tatsumi, T. Murohara, T. Imaizumi, Y. Katsuda, and M. Ito Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia Am Heart J 156 2008 1010 1018
7. Y. Saito, K. Sasaki, Y. Katsuda, T. Murohara, Y. Takeshita, and T. Okazaki Effect of autologous bone marrow cell transplantation on ischemic ulcer in patients with Burger's disease Circ J 71 2007 1187 1192
8. P. Hernández, L. Cortina, H. Artaza, N. Pol, R.M. Lam, and E. Dorticós Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation Atherosclerosis 194 2007 e52 e56
9. T. Horie, R. Onodera, M. Akamastu, Y. Ichikawa, J. Hoshino, and E. Kaneko Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells Atherosclerosis 208 2010 461 466
10. J.M. Isner, A. Pieczek, R. Schainfeld, R. Blair, L. Haley, and T. Asahara Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb Lancet 348 1996 370 374
11. I. Baumgartner, A. Pieczek, O. Manor, R. Blair, M. Kearney, and K. Walsh Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia Circulation 97 1998 1114 1123
12. D.W. Losordo, P.R. Vale, J.F. Symes, C.H. Dunnington, D.D. Esakof, and M. Maysky Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia Circulation 98 1998 2800 2804
13. T.K. Rosengart, L.Y. Lee, S.R. Patel, T.A. Sanborn, M. Parikh, and G.W. Bergman Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expression VEGF121 cDNA to individuals with clinically significant severe coronary artery disease Circulation 100 1999 468 474
14. C. Kalka, H. Masuda, T. Takahashi, W.M. Kalka-Moll, M. Silver, and M. Kearney Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization Proc Natl Acad Sci U S A 97 2000 3422 3427
15. A. Kawamoto, H.C. Gwon, H. Iwaguro, J.I. Yamaguchi, S. Uchida, and H. Masuda Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia Circulation 103 2001 634 637
16. S. Murasawa, and T. Asahara Endothelial progenitor cells for vasculogenesis Physiology 20 2005 36 42
17. J.W. Olin Thromboangiitis obliterans (Buerger's disease) N Engl J Med 343 2000 864 869
18. J.M. Isner, and T. Asahara Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization J Clin Invest 103 1999 1231 1236
19. D.W. Losordo, and S. Dimmeler Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines Circulation 109 2004 2487 2491
20. D.W. Losordo, and S. Dimmeler Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part II: cell-based therapies Circulation 109 2004 2692 2697
21. R.J. Powell, P. Goodney, F.O. Mendelsohn, E.K. Moen, B.H. Annex, and HGF-0205 Trial Investigators Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial J Vasc Surg 52 2010 1525 1530
22. P.P. Huang, S.Z. Li, M.Z. Han, Z.J. Xiao, R.C. Yang, and L.G. Qiu Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities Thromb Haemost 91 2004 606 609
23. A. Kawamoto, and T. Asahara Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies Catheter Cardiovasc Interv 70 2007 477 484
24. I. Flamme, and W. Risau Induction of vasculogenesis and hematopoiesis in vitro Development 116 1992 435 439
25. A. Kawamoto, M. Katayama, N. Handa, M. Kinoshita, H. Takano, and M. Horii Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial Stem Cells 27 2009 2857 2864
26. O.M. Tepper, R.D. Galiano, J.M. Capla, C. Kalka, P.J. Gagne, and G.R. Jacobowitz Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures Circulation 106 2002 2781 2786
27. F. Shalaby, J. Rossant, T.P. Yamaguchi, M. Gertsenstein, X.F. Wu, and M.L. Breitman Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice Nature 376 1995 62 66
28. N. Ferrara, K. Carver-Moore, H. Chen, M. Dowd, L. Lu, and K.S. O'Shea Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene Nature 380 1996 439 442
29. P. Carmeliet, V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, and M. Gertsenstein Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 380 1996 435 439